Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 HER2 Positive Metastatic Breast Cancer 3 Stomach Neoplasms 1 Non-squamous NSCLC 1 Non Small Cell Lung 1 HER2-positive Breast Cancer 1 HER2-expressing Advanced Solid Tumors 1 HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane 1 HER2 Positive Gastric Cancer 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pyrotinib 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Non-squamous NSCLC × pyrotinib × Clear all

NCT04447118 2025-12-19

PYRAMID-1

Jiangsu HengRui Medicine Co., Ltd.

Phase 3 Completed

Non-squamous NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡